ask="4.98"
ask_size="1000"
average_daily_volume="413168"
bid="3.33"
bid_size="100"
book_value="3.74"
change="+0.16"
change_from_200_day_moving_average="2.00"
change_from_50_day_moving_average="0.02"
change_from_52_week_high="-2.30"
change_From_52_week_low="3.60"
change_in_percent="+3.76%"
close="4.42"
dividend_pay_date="N/A"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-3.37"
ebitda="-41.42M"
eps_estimate_current_year="5.02"
eps_estimate_next_quarter="-0.50"
eps_estimate_next_year="-2.03"
ex_dividend_date="N/A"
float_shares="13913000"
high="4.45"
high_52_weeks="6.72"
last_trade_date="2/6/2017"
last_trade_price="4.42"
last_trade_size="4542"
last_trade_time="4:00pm"
low="4.26"
low_52_weeks="0.82"
market_capitalization="99.68M"
moving_average_200_day="2.42"
moving_average_50_day="4.40"
name="Cascadian Therapeutics
Inc."
notes="N/A"
one_year_target_price="390.00"
open="4.28"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+82.33%"
percent_change_from_50_day_moving_average="+0.42%"
percent_change_from_52_week_high="-34.23%"
percent_change_from_52_week_low="+439.02%"
previous_close="4.26"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.14"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="22551000"
short_ratio="6.55"
stock_exchange="NMS"
symbol="CASC"
volume="270879"
weeks_range_52="0.82 - 6.72"
